NMDA Receptor–Mediated Ca2+ Flux Attenuated by the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin
ABSTRACT Transient receptor potential melastatin‐4 (TRPM4) forms a complex with N‐methyl‐D‐aspartate receptors (NMDARs) that facilitates NMDAR‐mediated neurotoxicity. Here we used pharmacological tools to determine how TRPM4 regulates NMDAR signaling. Brophenexin, a compound that binds to TRPM4 at t...
Saved in:
Main Authors: | Jordan Casby, Benjamin M. Gansemer, Stanley A. Thayer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.70038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review
by: Jingliang Zhang, et al.
Published: (2025-02-01) -
Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus
by: Shunsei Hirohata, et al.
Published: (2019-12-01) -
Roles of TRPM channels in glioma
by: Zhigang Chen, et al.
Published: (2024-12-01) -
Humanin Rescues Cultured Rat Cortical Neurons from NMDA-Induced Toxicity Not by NMDA Receptor
by: Ai-Ling Cui, et al.
Published: (2014-01-01) -
Anti-NMDA Receptor Encephalitis Presenting with Prosopagnosia
by: Jayksh Chhabra, et al.
Published: (2024-12-01)